Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board ...

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon's Board of Directors

CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick Beddingfield, III, M.D., Ph.D., a 22-year veteran of the biopharma industry, to its Board of Directors. Dr. Beddingfield is currently CEO and Board Director of Rubedo Life Sciences and has led the development and approvals of global leadi…

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board ...

CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick Beddingfield, III, M.D., Ph.D., a 22-year veteran of the biopharma industry, to…

Frederick Beddingfield Joins Neurodon Board Of Directors

Dr. Beddingfield is a 22-year veteran of the biopharma industry